Lineage Cell Therapeutics, Inc., a clinical-stage biotechnology company, developing cell replacement therapies to treat serious medical conditions in the United States and internationally. The company develops OpRegen, an allogeneic retinal...
Q2 2026
Aug 11, 2026
Q1 2026
May 12, 2026
FY 2025
Mar 5, 2026
Q4 2025
Q3 2025
Nov 6, 2025